HSY
43
3
EXPE
96
-3
AES
41
2
FRT
48
2
HRL
30
-3
CMS
58
-2
TEL
74
3
EQR
60
6
GOOG
69
-10
HUM
48
2
TAP
64
4
R
77
2
KSS
42
-3
DFS
67
-3
LEN
52
2
AIZ
78
2
AA
38
-2
PDCO
30
-6
INTC
49
16
NOC
40
-10
HSY
43
3
EXPE
96
-3
AES
41
2
FRT
48
2
HRL
30
-3
CMS
58
-2
TEL
74
3
EQR
60
6
GOOG
69
-10
HUM
48
2
TAP
64
4
R
77
2
KSS
42
-3
DFS
67
-3
LEN
52
2
AIZ
78
2
AA
38
-2
PDCO
30
-6
INTC
49
16
NOC
40
-10
Financhill
Back

Dyne Therapeutics Stock Predictions

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.
Buy
66

DYN
Dyne Therapeutics

Last Price:
30.40
Seasonality Move:
38.02%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.

Dyne Therapeutics Stock Forecast

  • Over the next 52 weeks, Dyne Therapeutics has on average historically risen by 37.7% based on the past 4 years of stock performance.
  • Dyne Therapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
  • Is Dyne Therapeutics Stock Undervalued?
    The current Dyne Therapeutics [DYN] share price is $34.14. The Score for DYN is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • DYN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Dyne Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Dyne Therapeutics has on average historically risen by 37.7% based on the past 4 years of stock performance.

Dyne Therapeutics Stock Rating

Buy
66
Dyne Therapeutics (DYN) is a Buy

Is Dyne Therapeutics overpriced?

  • Dyne Therapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%

Dyne Therapeutics Stock Price History

Is DYN stock going to rise?

  • The current trend is relatively stagnant and DYN is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
dyne-tx.com

52-Week Data

52-Week High:
47.45
52-Week Low:
9.26

Prediction Charts

Market Cap:
3.43B
Price in USD:
34.14
Volume:
2.22M
Beta:
1.09

Technical Analysis

SMA50:
32.62
SMA100:
37.04
SMA200:
32.06
52-Wk Change:
292.41%

Stock Predictions

  • Is Dyne Therapeutics stock public?
    Yes, Dyne Therapeutics is a publicly traded company.
  • What is the Dyne Therapeutics stock quote today?
    The Dyne Therapeutics stock price is 34.14 USD today.
  • How to buy Dyne Therapeutics stock online?
    You can buy Dyne Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-25 31.22 30.73 31.83 30.67
Oct-28 31.49 30.85 31.55 30.65
Oct-29 30.67 30.22 30.67 29.94
Oct-30 29.98 29.20 30.61 28.99
Oct-31 29.09 28.86 29.21 28.22
Nov-1 29.09 28.74 29.23 27.66
Nov-4 28.01 28.78 29.21 27.92
Nov-5 28.70 28.62 29.01 28.25
Nov-6 29.92 29.80 30.43 29.31
Nov-7 29.86 29.27 30.97 29.20
Nov-8 29.29 28.48 29.55 28.13
Nov-11 29.01 28.13 29.75 28.10
Nov-12 28.04 29.38 31.38 27.99
Nov-13 29.12 34.14 35.68 29.02

Dyne Therapeutics Earnings

Dyne Therapeutics Earnings Report: Per Share Dyne Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Dyne Therapeutics Forecast Revenue Growth

Dyne Therapeutics Stock Analysis: Historical quarterly revenues per share for Dyne Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and an increase next year of $0.08 per share.

* Dyne Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.